Concerns over AstraZeneca vaccine disrupts vaccination campaigns
On
DR Congo postpones roll-out
By Sola Ogundipe & Chioma Obinna
The spate of concerns over COVID-19 vaccines and the AstraZeneca-Oxford vaccine, in particular, is fast constituting a threat to vaccination campaign plans globally.
Not less than 20 countries in Europe, Asia, and Africa, have either suspended or postponed their COVID-19 vaccination campaign plans.
The key concerns are the cases of bleeding, blood clots, and low platelet counts among people who received the AstraZeneca shot.
As the World Health Organisation (WHO) reviews the available vaccine data and addresses the concerns, global health experts are under increasing pressure to clear up questions over the safety of the AstraZeneca shot, just as more countries in Europe fully or partially suspended their use of the vaccine in a further blow to Europe’s vaccination rollout.
Concerns over AstraZeneca vaccine disrupts vaccination campaigns
today.ng - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from today.ng Daily Mail and Mail on Sunday newspapers.
Local Manufacturing in NIgeria Still Struggling Despite Govt s N1trn Grant
naija247news.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from naija247news.com Daily Mail and Mail on Sunday newspapers.
PSN cautions against use of Ivermectin for COVID-19
On
By Chioma Obinna
The Pharmaceutical Society of Nigeria, PSN, has called for caution against the use of Ivermectin in the treatment of COVID-19 even as it declared COVID-19 vaccines are safe for use in Nigeria.
The pharmacists decried that even with the availability of funds and infrastructure Nigeria cannot produce vaccines due to the absence of an effective Pharmacy law in the country.
Addressing a press conference on the Rollout of COVID-19 Vaccines in Lagos, the President of the Society, Pharm Sam Ohuabunwa appealed to health professionals and Nigerians at large to exercise caution in the use of the drug for non approved indications such as COVID-19 as every drug is a poison and can cause under-reported side effect or adverse events especially when used for new indications with the different dosing regimen.